A 4-week Study to Test Different Doses of BI 1265162 in Adolescents and Adults With Cystic Fibrosis Using the Respimat® Inhaler - BALANCE - CF™1
Clinical trial NCT04059094 · TERMINATED
Trial details
- NCT number
- NCT04059094
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-16
- Primary completion
- 2020-04-16
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.